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The in vitro antiprotozoal activities of crude methanolic extracts from the aerial parts of five Lamiaceae plants (Salvia tomentosa, S. sclarea, 
S. dichroantha, Nepeta nuda subsp. nuda and Marrubium astracanicum subsp. macrodon) were evaluated against four parasitic protozoa, i.e. 
Trypanosoma brucei rhodesiense, T. cruzi, Leishmania donovani and Plasmodium falciparum. The cytotoxic potentials of the extracts on    
L6 cells were also evaluated. Melarsoprol, benznidazole, miltefosine, chloroquine and podophyllotoxin were used as reference drugs. All 
crude MeOH extracts showed antiprotozoal potential against at least three parasites, so they were dispersed in water and partitioned against 
n-hexane and chloroform to yield three subextracts that were screened in the same test systems. The n-hexane extract of N. nuda was          
the most active against T. brucei rhodesiense while the CHCl3 extracts of S. tomentosa and S. dichroantha showed significant activity against 
L. donovani. All organic extracts displayed in vitro antimalarial and moderate trypanocidal activities against T. cruzi with the n-hexane 
extract of S. sclarea being the most active against the latter. The extracts displayed low or no cytotoxicity towards mammalian L6 cells.  
 




Tropical neglected diseases, i.e. African trypanosomiasis, 
Chagas disease, visceral leishmaniasis and malaria 
continue to be major health problems that affect millions 
of people worldwide. T. brucei rhodesiense, T. cruzi, 
Leishmania donovani, Plasmodium falciparum are the 
causative agents of these illnesses respectively [1a]. 
African trypanosomiasis, more commonly known as 
sleeping sickness, is caused by single-celled protozoa from 
the Trypanosoma genus. One of the two major species that 
infect humans is Trypanosoma brucei rhodesiense. The 
disease is limited to Africa, and outbreaks tend to affect 
isolated rural areas. Around 12,000 new cases were 
reported in 2006 [1b]. Chagas’ disease (American 
trypanasomiasis) is an indigenous disease of 22 countries 
in the Western Hemisphere caused by the protozoa 
Trypanosoma cruzi [1c,2]. It has been estimated that there 
are 15-17 million people infected by T. cruzi in Latin 
America and 90-100 million are exposed to infection [3]. 
Leishmaniasis is caused by obligate intracellular and 
kinetoplastid protozoa of the genus Leishmania that is 
endemic to 88 countries with 350 million people at risk of 
infection [4a].  Parallel infections with diseases such as 
malaria and pneumonia increases the fatality of the illness, 
as do parallel infections of AIDS and the development     
of drug-resistance by the parasites [4b]. Visceral 
leishmaniasis, also known as kala-azar, is caused by 
Leishmania donovani [4c]. Malaria infects 300-500 million 
people and kills over 1 million people annually.  Human 
malaria is endemic to 90 countries and is caused by the 
protozoa Plasmodium falciparum [4d].   
 
The Lamiaceae family of mostly medicinal and aromatic 
plants is represented by around 3000 species in 250 genera 
worldwide. Turkish flora contains 558 species and 45 
genera belonging to the Lamiaceae, almost half of which 
are endemic [5a]. Salvia (sage), the largest genus with 900 
species worldwide [5b] and 90 in Turkey is commonly 
known as “adaçayı” [5a]. It is traditionally used as herbal 
tea with carminative, spasmolytic, diuretic, antiseptic and 
wound healing properties, as well as against rheumatic and 
abdominal pains, cold and cough [5c-5e]. In South African 
traditional medicine, some Salvia species are reported to 
treat fever and febrile attacks [6].  In vitro antiplasmodial 
activities of several Salvia species against Plasmodium 
falciparum were also reported [7,8a]. The genus Nepeta is 
represented by 33 species in Turkish flora and half of these 
species are endemic [5a] and used in traditional medicine 
to treat bronchitis [8b]. The genus Marrubium consists of 
perennial herbs of which 18 species grow in Turkey [5a]. 
Some species are used to treat bronchitis, cough, fever and 
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asthma in folk medicine [9,10a]. Promising anti-microbial 
activity of M. vulgare extracts against Gram-positive 
bacteria was reported [10b]. As part of the systematic 
survey of the antiprotozoal activities of Turkish medicinal 
plants [10c,11a,11b] this study describes the in vitro 
antimalarial, trypanocidal, leishmanicidal and the cytotoxic 
activities of extracts of five Lamiaceae herbs of the genera 
Salvia, Nepeta and Marrubium native to Turkey. 
 
In order to evaluate their in vitro antiprotozoal activity, the 
crude methanolic extracts of Salvia tomentosa, S. sclarea, 
S. dichroantha, Nepeta nuda subsp. nuda and Marrubium 
astracanicum subsp. Macrodon) were tested in vitro 
against four parasitic protozoa, Trypanosoma brucei 
rhodesiense, T. cruzi, Leishmania donovani and 
Plasmodium falciparum. The extracts were simultaneously 
tested on rat skeletal myoblasts (L6 cells) in order to 
determine their selectivity. Table 1 shows the results. All 
crude MeOH extracts displayed antiprotozoal potential 
against at least three parasites without any cytotoxicity. 
This includes trypanocidal activity against T. brucei 
rhodesiense with the extracts of N. nuda (Nn-MeOH), S. 
dichroantha (Sd-MeOH) and S. sclarea (Ss-MeOH) being 
the most potent, antileishmanial activity against L. 
donovani amastigotes, with Sd-MeOH showing the highest 
activity, and antiplasmodial activity with the extracts of 
Marrubium astracanicum subsp. macrodon (Ma-MeOH) 
and Ss-MeOH displaying the highest activity. On the 
contrary, all MeOH extracts were inactive against T. cruzi 
except for S. sclarea, which had mild activity.  
Remarkably, only the S. sclarea MeOH extract showed a 
marginal cytotoxicity against mammalian cells.  
 
The crude MeOH extracts were dispersed in H2O and 
partitioned first against n-hexane, and then against CHCl3. 
All three subextracts (n-hexane, CHCl3 and H2O) were 
screened as shown in Table 1. All organic extracts showed 
antiprotozoal activity in varying degrees. Against T. brucei 
rhodesiense, the n-hexane extract of N. nuda (Nn-Hexane) 
showed very significant activity followed by the n-hexane 
(St-Hexane) and CHCl3 extracts (St-CHCl3) of S. tomen-
tosa and the n-hexane extract of S. sclarea (Ss-Hexane). 
Interestingly, all aqueous extracts displayed trypanocidal 
potential with the water subextract of S. dichroantha (Sd-
H2O) being the most active and the water subextract of 
Marrubium astracanicum subsp. macrodon (Ma-H2O) 
being the least active. Against the American trypanosomes 
(T. cruzi), all organic extracts were only moderately active 
whereas all aqueous subextracts were inactive.  
 
All n-hexane and chloroform extracts had antileishmanial 
activity. The CHCl3- and n-hexane-solubles of S. 
tomentosa (St-CHCl3 and St-Hexane) and the CHCl3-
solubles of S. dichroantha (Sd-CHCl3) exhibited the most 
significant activity against L. donovani.   A similar 
bioactivity profile was apparent against the drug resistant 
malaria parasite P. falciparum, where all organic extracts 
were quite active and H2O extracts were not. The CHCl3 
extracts of S. sclarea and N. nuda were the most potent. 
When tested against mammalian L6 cells, only the organic 
extracts of S. tomentosa, the n-hexane  extract of S. sclarea 
and the CHCl3  extract of N. nuda showed cytotoxicity. 
The remaining extracts had marginal or no toxicity at the 
highest test concentrations (IC50s>90 µg/mL). 
 
Table 1: Trypanocidal, leismanicidal, antiplasmodial and cytotoxic 
activities of the solvent extracts of Salvia tomentosa (St), S. sclarea (Ss), 
S. dichroantha (Sd), Nepeta nuda subsp. nuda (Nn) and Marrubium 
astracanicum subsp. macrodon (Ma). All IC50 values are in g/mL. 
 










St-MeOH 3.64  >90 14.92 9.94 90 
St-Hexane 1.24  28.46 2.49  3.47 26.24 
St-CHCl3 2.33  35.72  1.81  3.14 31.8 
St-H2O 10.96 >90 >90 >20 >90 
Ss-MeOH 6.44  56.82 12.95  6.60  87.6 
Ss- Hexane 2.40 18.17  5.25  3.78  18.3 
Ss-CHCl3 4.40  52.51 8.31 2.54  83.9 
Ss-H2O 10.31 >90 47.88 >20 >90 
Sd-MeOH 3.58 >90 4.93 8.85 >90 
Sd-Hexane 3.50 41.85 3.48 4.17 >90 
Sd-CHCl3 4.40 48.99 2.31 3.72 84.8 
Sd-H2O 7.77 >90 >90 >20 >90 
Nn-MeOH 3.43 >90 15.26 11.31 >90 
Nn-Hexane 0.62  46.77  7.73 3.37 85 
Nn-CHCl3 3.57  55.98  4.08  2.95  46.2 
Nn-H2O 10.64 >90 >90 >20 >90 
Ma-MeOH 4.69 >90 15.81 6.39 >90 
Ma-Hexane 3.29 58.33 9.39 4.64  88.3 
Ma-CHCl3 8.56 49.56 7.17 3.36 >90 
Ma-H2O 35.90 >90 >90 >20 >90 
Reference drug 0.003a 0.359b 0.2c 0.056d 0.004e 
Reference compounds: aMelarsoprol, bbenznidazole, cmiltefosine, 
dchloroquine, epodophyllotoxin 
 
In summary, the organic extracts were generally the most 
potent probably due to enrichment of more lipophilic 
compounds. Overall T. brucei rhodesiense appears to be 
the most susceptible protozoan species and with the 
subg/mL level activity and almost no toxicity on 
mammalian cells, the hexane extract of N. nuda is very 
promising. With a selectivity index (=therapeutic index, 
calculated by dividing the IC50 value against L6 cells / the 
IC50 value against parasite) of 137, this extract clearly 
merits further activity-guided isolation studies which are 
currently underway in our laboratory. In general, the 
hexane subextracts had a higher activity than the CHCl3 
extracts against both Trypanosoma species. The organic 
subextracts, in particular the CHCl3 extracts proved to have 
good leishmanicidal and antiplasmodial properties. All 
three Salvia species investigated have remarkable 
antiprotozoal potential with S. dichroantha the most 
promising in terms of low toxicity profile. Despite the fact 
that only one Marrubium species was studied, M. 
astracanicum subsp. macrodon seems to be worthy of 
further chemical and biological studies, particularly for 
antiplasmodial activity. 
 
Several species of Salvia have been shown to exert 
antimalarial activity [11c]. The lipophilic extracts of Salvia 
species are rich in diterpenes and triterpenes [12a], several 
of which possess antileishmanial, [12b] trypanocidal   
[13a] and antimalarial [7] activities. Monoterpenoid 
nepetalactones, sterols and triterpenes have previously 
been isolated from the n-hexane extract of Nepeta nuda 
subsp. albiflora [13b], which may be responsible for the 
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antiparasitic activity. Likewise, the labdane diterpenoids 
and methoxylated flavones [9,13c] reported from the 
lipophilic extracts of Marrubium species could be 
responsible for the antiprotozoal activities of M. 




Plant material: Salvia tomentosa, S. sclarea, S. 
dichroantha, Nepeta nuda subsp. nuda and Marrubium 
astracanicum subsp. macrodon were collected in July 2008 
from Eskişehir, Turkey, and identified by Dr. Akaydin. The 
voucher specimens (Akaydın 10934, 11086, 10539, 11158 
and 11151, respectively) deposited at the Herbarium of the 
Faculty of Education, Hacettepe University, Ankara, Turkey. 
 
Preparation of the extracts: The air-dried and powdered 
aerial parts of each plant (20 g) were macerated overnight 
in MeOH (200 mL) and filtered. The residues were further 
extracted with MeOH (200 mL) at 45°C for 4 hours. After 
filtration and combination with the initial MeOH 
macerates, the crude methanolic extracts were evaporated 
and dried under vacuum. The extract yields were 15% for 
S. tomentosa and S. sclarea, 12% for S. dichroantha, 11% 
N. nuda subsp. nuda, and 10% for M. astracanicum subsp. 
macrodon. The crude MeOH extracts were dispersed in 
H2O (5 mL) and partitioned against n-hexane (3 x 5 mL) 
and CHCl3 (3 x 5 mL), respectively. The organic solvents 
were evaporated to dryness under reduced pressure while 
the H2O extracts were freeze-dried.  All the extracts were 
stored at -20°C until use. 
 
In vitro assay for Plasmodium falciparum: In vitro 
activity against erythrocytic stages of P. falciparum was 
determined by a modified [3H]-hypoxanthine incorporation 
assay, using the chloroquine- and pyrimethamine-resistant 
K1 strain and the standard drug chloroquine. Briefly, 
parasite cultures incubated in RPMI 1640 medium with 5% 
Albumax (without hypoxanthine) were exposed to serial 
drug dilutions in microtiter plates. After 48 h of incubation 
at 37°C in a reduced oxygen atmosphere, 0.5 Ci           
3H-hypoxanthine was added to each well. Cultures were 
incubated for a further 24 h before they were harvested 
onto glass-fiber filters and washed with distilled water. 
The radioactivity was counted using a BetaplateTM liquid 
scintillation counter (Wallac, Zurich, Switzerland). The 
results were recorded as counts per minute (CPM) per well 
at each drug concentration and expressed as percentage of 
the untreated controls. IC50 values were calculated from the 
sigmoidal inhibition curves using Microsoft Excel. 
 
In vitro assay for Trypanosoma brucei rhodesiense: T. b. 
rhodesiense, STIB 900 strain, and the standard drug, 
melarsoprol, were used for the assay. This stock was 
isolated in 1982 from a human patient in Tanzania and 
after several mouse passages cloned and adapted to axenic 
culture conditions. Minimum Essential Medium (50 µL) 
supplemented with 25 mM HEPES, 1g/l additional 
glucose, 1% MEM non-essential amino acids (100x), 0.2 
mM 2-mercaptoethanol, 1mM Na-pyruvate and 15% heat 
inactivated horse serum was added to each well of a 96-
well microtiter plate. Serial drug dilutions of seven 3-fold 
dilution steps were prepared. Then 104 bloodstream forms 
of T. b. rhodesiense STIB 900 in 50 µL was added to each 
well and the plate incubated at 37°C under a 5% CO2 
atmosphere for 72 h. 10 µL Alamar Blue (resazurin, 12.5 
mg in 100 mL double-distilled water) was then added to 
each well and incubation continued for a further 2-4 h. 
Then the plates were read with a Spectramax Gemini XS 
microplate fluorometer (Molecular Devices Cooperation, 
Sunnyvale, CA, USA) using an excitation wavelength of 
536 nm and an emission wavelength of 588 nm. Data were 
analyzed using the microplate reader software Softmax Pro 
(Molecular Devices Cooperation, Sunnyvale, CA, USA). 
 
In vitro assay for Trypanosoma cruzi: Rat skeletal 
myoblasts (L-6 cells) were seeded in 96-well microtitre 
plates at 2000 cells/well in 100 μL RPMI 1640 medium with 
10% FBS and 2 mM l-glutamine. After 24 h the medium 
was removed and replaced by 100 μL per well containing 
5000 trypomastigote forms of T. cruzi Tulahuen strain C2C4 
containing the β-galactosidase (Lac Z) gene. After 48 h, the 
medium was removed from the wells and replaced by 100 μl 
fresh medium with or without a serial drug dilution. After 
96 h of incubation the plates were inspected under an 
inverted microscope to assure growth of the controls and 
sterility. Then the substrate CPRG/Nonidet (50 μL) was 
added to all wells. A color reaction developed within 2-6 h 
and could be read photometrically at 540 nm. Data were 
transferred into the graphic programme Softmax Pro 
(Molecular Devices), which calculated IC50 values. 
Benznidazole was the standard drug used. 
 
In vitro assay for Leishmania donovani: Amastigotes of 
L. donovani strain MHOM/ET/67/L82 were grown in 
axenic culture at 37°C in SM medium at pH 5.4 
supplemented with 10% heat-inactivated fetal bovine 
serum under an atmosphere of 5% CO2 in air. One hundred 
microlitres of culture medium with 105 amastigotes from 
axenic culture with or without a serial drug dilution were 
seeded in 96-well microtitre plates. Serial drug dilutions 
were prepared. After 72 h of incubation the plates were 
inspected under an inverted microscope to assure growth 
of the controls and sterile conditions. Alamar Blue (10 μL; 
12.5 mg resazurin dissolved in 100 ml distilled water) were 
then added to each well and the plates incubated for 
another 2 h. Then the plates were read with a Spectramax 
Gemini XS microplate fluorometer using an excitation 
wavelength of 536 nm and an emission wavelength of 588 
nm. Data were analyzed using the software Softmax Pro 
(Molecular Devices Cooperation, Sunnyvale, CA, USA). 
Decrease of fluorescence (= inhibition) was expressed as 
percentage of the fluorescence of control cultures and 
plotted against the drug concentrations. From the 
sigmoidal inhibition curves the IC50 values were 
calculated. Miltefosine was used as a reference drug. 
 
In vitro assay for cytotoxicity: Assays were performed in 
96-well microtiter plates, each well containing 100 μL of 
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RPMI 1640 medium supplemented with 1% L-glutamine 
(200 mM) and 10% fetal bovine serum, and 4 x 104 L6 
cells (a primary cell line derived from rat skeletal 
myoblasts). Serial drug dilutions of seven 3-fold dilution 
steps covering a range from 90 to 0.123 μg/mL were 
prepared. After 72 h of incubation the plates were 
inspected under an inverted microscope to assure growth 
of the controls and sterile conditions. Alamar Blue (10 L, 
12.5 mg resazurin dissolved in 100 ml double-distilled 
water) was then added to each well and the plates 
incubated for another 2 h. Then the plates were read with a 
Spectramax Gemini XS microplate fluorometer using an 
excitation wavelength of 536 nm and an emission 
wavelength of 588 nm. Data were analysed using the 
microplate reader software Softmax Pro. Podophyllotoxin 
was the standard drug used. 
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